Cardiff Oncology Inc (CRDF) Stock Split History

Cardiff Oncology Inc has split its stock 3 times since its initial public offering (IPO). The first stock split occurred on May 30, 2012 with the ratio of 1-for-6, meaning that for 6 shares of CRDF owned pre-split, shareholders then owned 1 share. 2 more splits have been implemented since then. The most recent stock split took place on February 20, 2019 on a 1-for-6 basis.

These splits have increased CRDF stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Cardiff Oncology Inc's total market capitalization.

For more detailed information of Cardiff Oncology Inc's stock splits, view the table below:

The answer will depend on the decisions of the company's managers and market volatility. Cardiff Oncology Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when CRDF stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Cardiff Oncology Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.